{"id":"NCT02442284","sponsor":"AbbVie","briefTitle":"A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection","officialTitle":"An Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in US Veterans With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (TOPAZ-VA)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-05-13","primaryCompletion":"2016-08-22","completion":"2016-10-31","firstPosted":"2015-05-13","resultsPosted":"2017-08-30","lastUpdate":"2017-10-16"},"enrollment":99,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C","Cirrhosis","Hepatitis C Virus"],"interventions":[{"type":"DRUG","name":"ombitasvir/paritaprevir/ritonavir and dasabuvir","otherNames":["Viekira Pak","paritaprevir also known as ABT-450","ombitasvir also known as ABT-267","dasabuvir also known as ABT-333"]},{"type":"DRUG","name":"Ribavirin","otherNames":[]}],"arms":[{"label":"3-DAA ± RBV for 12 or 24 weeks","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin in US veterans with genotype 1 chronic hepatitis C virus infection.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response 12 Weeks Post-treatment (SVR12)","timeFrame":"12 weeks after the last actual dose of study drug","effectByArm":[{"arm":"3-DAA ± RBV for 12 or 24 Weeks","deltaMin":93.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":99},"commonTop":["FATIGUE","HEADACHE","NAUSEA","INSOMNIA","PRURITUS"]}}